Drugs / ICI201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05980507 | Oct 2023 | refractory plasma cell neoplasm | The First Affiliated Hospital of Soochow University | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ICI201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05980507 ↗ |
| Modality | Cell therapy | “ICI201 CAR-T cell injection” NCT05980507 ↗ |